Results 231 to 240 of about 24,231 (256)

Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population

Journal of the American Heart Association, 2015
Wei-Shiung Yang, Li-Chun Chang, Wei-Chih Liao   +2 more
exaly  

QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update

Psychosomatics, 2018
Alan Sugrue, Jeff Huffman
exaly  

Chronic Arsenic Exposure and Cardiac Repolarization Abnormalities with QT Interval Prolongation in a Population-based Study

Environmental Health Perspectives, 2007
Richard K Kwok, Kegong Wu, Judy L Mumford   +2 more
exaly  

The impact of drug-induced QT interval prolongation on drug discovery and development

Nature Reviews Drug Discovery, 2003
Anthony Fossa, Bernard Fermini
exaly  

Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice

British Journal of Clinical Pharmacology, 2013
Colin Page, Geoffrey Isbister
exaly  

QTc prolongation indicates a poor prognosis in patients with organophosphate poisoning

American Journal of Emergency Medicine, 1996
Jin-Bor Chen, Ja-Liang Lin, Feng-Rong Chuang   +2 more
exaly  

Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?

Journal of Electrocardiology, 2009
Dan Justo
exaly  

QT interval prolongation

2017
openaire   +1 more source

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

Medicinal Research Reviews, 2005
Maurizio Recanatini, Fabrizio De Ponti, Matteo Masetti   +2 more
exaly  

Prolonged QT interval

2014
openaire   +1 more source